Report Content
Chapter 1 Methodology
1.1 Market definition
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data joint types
1.5.1 Secondary
1.5.1.1 Paid joint types
1.5.1.2 Unpaid joint types
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Joint pain injection 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Form trends
2.1.3 Source trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Joint pain injection Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 – 2032 (USD Million)
3.3 Industry impact factors
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of orthopaedic diseases
3.3.1.2 Technological advancements
3.3.1.3 Rising demand for knee pain injections
3.3.1.4 Therapeutics advantages to relieve joint pain & inflammation
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of joint pain injections
3.3.2.2 Side effects associated with joint pain injections
3.4 Growth potential analysis
3.4.1 By injection type
3.4.2 By joint type
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2022
3.7.1 Company matrix analysis, 2022
3.8 PESTEL analysis
Chapter 4 Joint Pain Injections Market, By injection type
4.1 Key segment trends
4.2 Hyaluronic acid injections
4.2.1 Market size, by region, 2018 – 2032 (USD Million)
4.3 Corticosteroid injections
4.3.1 Market size, by region, 2018 – 2032 (USD Million)
4.4 Platelet rich plasma injections
4.4.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 5 Joint Pain Injections Market, By joint type
5.1 Key segment trends
5.2 Knee
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Shoulder & elbow
5.3.1.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Ankle & hip
5.4.1.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Others
5.5.1.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Joint Pain Injections Market, By end use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Clinics
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Others
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Joint Pain Injections Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2018 - 2032 (USD Million)
7.2.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.2.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.2.4 Market size, by end use, 2018 - 2032 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.2.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.2.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.2.5.4 Market size, by end use, 2018 - 2032 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.2.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.2.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.2.6.4 Market size, by end use, 2018 - 2032 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.3.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.3.4 Market size, by end use, 2018 - 2032 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.3.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.3.5.4 Market size, by end use, 2018 - 2032 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.3.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.3.6.4 Market size, by end use, 2018 - 2032 (USD Million)
7.3.7 France
7.3.7.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.3.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.3.7.4 Market size, by end use, 2018 - 2032 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.8.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.3.8.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.3.8.4 Market size, by end use, 2018 - 2032 (USD Million)
7.3.9 Spain
7.3.9.1 Market size, by country, 2018 - 2032 (USD Million)
7.3.9.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.3.9.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.3.9.4 Market size, by end use, 2018 - 2032 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.4.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.4.4 Market size, by end use, 2018 - 2032 (USD Million)
7.4.5 China
7.4.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.4.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.4.5.4 Market size, by end use, 2018 - 2032 (USD Million)
7.4.6 Japan
7.4.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.4.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.4.6.4 Market size, by end use, 2018 - 2032 (USD Million)
7.4.7 India
7.4.7.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.4.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.4.7.4 Market size, by end use, 2018 - 2032 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.8.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.4.8.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.4.8.4 Market size, by end use, 2018 - 2032 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by country, 2018 - 2032 (USD Million)
7.4.9.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.4.9.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.4.9.4 Market size, by end use, 2018 - 2032 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.5.4 Market size, by end use, 2018 - 2032 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.5.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.5.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.5.5.4 Market size, by end use, 2018 - 2032 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.5.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.5.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.5.6.4 Market size, by end use, 2018 - 2032 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by country, 2018 - 2032 (USD Million)
7.5.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.5.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.5.7.4 Market size, by end use, 2018 - 2032 (USD Million)
7.6 Middle East and Africa
7.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.6.4 Market size, by end use, 2018 - 2032 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by country, 2018 - 2032 (USD Million)
7.6.5.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.6.5.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.6.5.4 Market size, by end use, 2018 - 2032 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by country, 2018 - 2032 (USD Million)
7.6.6.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.6.6.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.6.6.4 Market size, by end use, 2018 - 2032 (USD Million)
7.6.7 UAE
7.6.7.1 Market size, by country, 2018 - 2032 (USD Million)
7.6.7.2 Market size, by injection type, 2018 - 2032 (USD Million)
7.6.7.3 Market size, by joint type, 2018 - 2032 (USD Million)
7.6.7.4 Market size, by end use, 2018 - 2032 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2022
8.2 Zimmer Biomet
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Anika Therapeutics, Inc.
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Bioventus
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Sanofi
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Pacira BioSciences (Flexion)
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 OrthogenRx
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Pfizer
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Ferring B.V.
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Lifecore Biomedical
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Wright Medical Group (Stryker)
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Stryker
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 9.12. Emcyte Corporation
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Arthrex
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
